HRMY
Harmony BiosciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
HRMY vs peer average
54/100
HRMY vs. peer average (C vs. C)
Grade spread
B 1 · C 7 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANIP is the first available peer comparator.
ANI Pharmaceuticals is a somewhat closer commercial specialty-pharma comparator by size than large-cap biotech names, but its portfolio mix is broader and less tied to a single sleep-wake franchise, so read-through to HRMY is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
HRMY
Harmony Biosciences
ANIP
ANI
Grade
C
B
Momentum
42
45
Value
71
67
Sentiment
53
70
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ANIP
HRMY / ANIP
Grade Position
In line
HRMY vs. peer average (C vs. C)
54/100
Momentum
42
ANIPValue
71
HRMYSentiment
53
ANIPRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs HRMY
ANIP is the first peer returned for this comparison set.